Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Prospective Study to Assess Tissue Responses After Injection With Biostimulatory Products

NCT: NCT06093815 · COMPLETED

NCT IDNCT06093815
StatusCOMPLETED
Start Date2023-09-08
Completion2024-11-01
SponsorMerz North America, Inc. (INDUSTRY)
First posted
Last updated

Brief Summary

The objective of this study is to identify and assess in vivo tissue responses after injection with various biostimulatory products at various timepoints. The study will also provide tissue specimens which will be used in a subsequent study. Safety endpoint: incidence of adverse events.

Frequently Asked Questions

What is Prospective Study to Assess Tissue Responses After Injection With Biostimulatory Products?

Prospective Study to Assess Tissue Responses After Injection With Biostimulatory Products is a clinical trial registered under NCT06093815. Current status: COMPLETED.

What is the status of NCT06093815?

The current status of NCT06093815 (Prospective Study to Assess Tissue Responses After Injection With Biostimulatory Products) is: COMPLETED.

When did Prospective Study to Assess Tissue Responses After Injection With Biostimulatory Products start?

Prospective Study to Assess Tissue Responses After Injection With Biostimulatory Products started on 2023-09-08.

Related Devices

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.